Search

You searched for "incontinence"

423 results found
The Journal of Urology with online exclusive stamp image.

Long-term risks of augmenting the bladder in spina bifida patients

6 November 2020 | | URO - Paediatric Urology
Bladder augmentation is utilised to treat children with neuropathic bladders secondary to spina bifida that results in hostile urodynamics, renal deterioration and / or urinary incontinence. Whilst it is associated with an improved quality of life and low mortality, it...

Transurethral enucleation is superior to resection for the management of LUTS secondary to BPH

7 July 2020 | | URO - Endourology & Stones
This meta-analysis (Level 1b evidence) examined the efficacy and safety of two primary transurethral therapies used in the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), enucleation (HoLEP – holmium laser enucleation of prostate, ThuLEP,...

Solifenacin for children and adolescents with overactive bladders

1 January 2018 | | URO - Basic Science Research, URO - Functional / Reconstructive Urology, URO - Paediatric Urology
Solifenacin (VESIcare®) is the second-line anti-muscarinic medication of choice for my patients with overactive bladder (oxybutynin being my initial choice). However, currently, it remains unlicensed for use in children. Newgreen et al. have evaluated the long-term safety and efficacy of...

Solifenacin and mirabegron are safe and effective in combination

1 September 2015 | | URO - Functional / Reconstructive Urology
Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...

Neurourology

4 September 2020 | | URO - Neurourology
Case 1 What are the urological indications for use of this medication? What is the mechanism of action when used in the bladder? What is the average duration of action? What are the contraindications to the use of this medication?...

Prolapse surgery with mesh: where do we stand in 2017? An ICS update

1 November 2017 | | URO - Functional / Reconstructive Urology
Background Surgery for pelvic organ prolapse (POP) is common among women. The lifetime risk of undergoing at least one surgical procedure for POP is up to 20% [1]. This kind of surgery will be increasingly important due to an ageing...

BBS Revolution™ bladder scanner

5 May 2021 | Research & Development
Featuring a wireless scanning probe with eight ultrasound transducers for fully automatic bladder detection, BBS Revolution™ differentiates between male/female anatomy, delivering accurate measurements in seconds. Simple to use BBS Revolution™ can be used with/without prior...

ICS updates on continence care: making sense of detrusor underactivity and the underactive bladder

1 July 2016 | | URO - Functional / Reconstructive Urology
Countless epidemiological studies have established the frequent occurrence of lower urinary tract symptoms (LUTS) and the significant burden these symptoms incur. For the most part of the past three decades, there has been an overwhelming focus on detrusor overactivity (DO)...

Updated guide on integrated paediatric continence services to significantly improve children’s lives and save NHS cost

30 May 2024 | URO - Functional / Reconstructive Urology, URO - Paediatric Urology
The Paediatric Continence Forum has recently launched its updated Guide on how to commission and run integrated, nurse-led, community-based paediatric bladder and bowel (continence) services. These are clinically effective, improve the lives of children and their families and generate significant...

Balanitis xerotica obliterans

1 September 2018 | | URO - Andrology, URO - Urologic Oncology
Balanitis xerotica obliterans (BXO) / lichen sclerosus of the male genitalia is a common cause of acquired phimosis, and was first described by Stuhmer in 1928 [1]. It is described in medical literature as a chronic inflammatory condition of unknown...

How the COVID pandemic has shaped ongoing service delivery at ERIC, The Children’s Bowel & Bladder Charity

6 January 2023 | URO - Covid-19
- CHARITY FOCUS - Like many organisations and charities, COVID-19 generated a rapid period of adaptation and diversification for ERIC, The Children’s Bowel and Bladder Charity. Their Head of Communications, Alina Lynden, explains what this meant for the organisation and...

The impact of menopause on bladder symptoms

11 July 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
The menopause is a natural process of ageing when the ovaries completely stop producing reproductive hormones (oestrogen and other sex steroids), and there are no monthly periods for 12 consecutive months. It normally occurs between the ages of 45-55 years...